celecoxib and s20098
celecoxib has been researched along with s20098 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fang, P; He, J; Liu, T; Wang, C; Wen, J; Xu, RA; Zhang, B; Zheng, X | 1 |
Other Studies
2 other study(ies) available for celecoxib and s20098
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo.
Topics: Acetamides; Administration, Oral; Animals; Celecoxib; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Microsomes, Liver; Molecular Structure; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Structure-Activity Relationship | 2018 |